Filing Details
- Accession Number:
- 0001209191-16-104454
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-02 16:20:37
- Reporting Period:
- 2016-02-29
- Filing Date:
- 2016-03-02
- Accepted Time:
- 2016-03-02 16:20:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189844 | J Robert Easton | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-29 | 12,500 | $9.26 | 22,519 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-02-29 | 12,500 | $31.13 | 10,019 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2016-02-29 | 12,500 | $0.00 | 12,500 | $9.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-04-29 | 2016-04-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,175 | Indirect | See Footnote |
Common Stock | 73,856 | Indirect | See Footnote |
Footnotes
- Shares held by Joan Easton, the Reporting Person's spouse.
- Shares are held by the Second Easton Family Charitable Trust of which the Reporting Person is the trustee.
- The purchase price reported is the weighted average purchase price for the number of shares purchased. Full information regarding the number of shares purchased at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
- 100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date.